An ankle pressure alone does not show how that value relates to the patient’s arm pressure. The ABI expresses that relationship by dividing the higher ankle systolic pressure by the higher brachial systolic pressure. The resulting ratio provides a standardized basis for recognizing reduced lower-extremity arterial circulation and estimating peripheral artery disease severity.
These two abnormal patterns have different clinical implications. A reduced ABI can indicate peripheral artery disease and may help estimate the severity of lower-extremity arterial impairment. In contrast, an unusually high value may reflect arteries that are stiff and poorly compressible, giving it a different clinical meaning from a reduced result.
An inflatable cuff is used to obtain systolic pressure readings at the arm and ankle. Those readings may be captured with Doppler ultrasound or an automated device, depending on the testing approach. Because the ABI calculation depends on pressures from both locations, cuff-based measurement at each site is essential to producing the vascular comparison.
Clinicians measure systolic pressure in the arm and at the ankle with an inflatable cuff, Doppler ultrasound, or an automated device. They select the higher arm and ankle values, divide the ankle value by the arm value, and interpret the ratio for lower-extremity arterial circulation. The result can then support screening or further clinical assessment.
ABI is useful when clinicians need information for vascular screening, peripheral artery disease diagnosis, risk assessment, treatment planning, or monitoring. Its result adds an objective comparison of ankle and arm pressures to the clinical evaluation. Because reduced values can indicate disease and help estimate severity, the test can support both initial assessment and ongoing care.
A reduced result can contribute to identifying peripheral artery disease and estimating its severity, information that supports vascular risk assessment and treatment planning. Repeated ABI testing can also help monitor vascular disease over time. Consequently, the measurement may provide clinically useful information beyond initial screening by helping assess the course of a patient’s vascular condition.